Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Norwitz ER and Wilson T | Secretory component: a potential regulator of endometrial-decidual prostaglandin production in early human pregnancy. | 2000 | Am. J. Obstet. Gynecol. | pmid:10920317 |
Rao PS et al. | Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses. | 1984 | Am. J. Obstet. Gynecol. | pmid:6424477 |
Rao PS et al. | Dose-dependent effects of prostaglandin D2 on hemodynamics, renal function, and blood gas analyses. | 1987 | Am. J. Obstet. Gynecol. | pmid:3555078 |
Zhang YF et al. | Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense. | 2006 | Am. J. Nephrol. | pmid:17183189 |
Chana RS et al. | Statins but not thiazolidinediones attenuate albumin-mediated chemokine production by proximal tubular cells independently of endocytosis. | 2008 | Am. J. Nephrol. | pmid:18535368 |
Zhang YJ et al. | Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2). | 2006 | Am. J. Nephrol. | pmid:16864989 |
Afrin LB | Polycythemia from mast cell activation syndrome: lessons learned. | 2011 | Am. J. Med. Sci. | pmid:21642812 |
Afrin LB | Mast cell activation syndrome as a significant comorbidity in sickle cell disease. | 2014 | Am. J. Med. Sci. | pmid:25171546 |
Newman JH and Sheller JR | Arachidonic acid metabolites in the healthy and diseased lung. | 1984 | Am. J. Med. Sci. | pmid:6091454 |
White RP et al. | Eicosanoid levels in CSF of premature infants with posthemorrhagic hydrocephalus. | 1990 | Am. J. Med. Sci. | pmid:2321665 |
Ruano D et al. | Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia. | 2007 | Am. J. Med. Genet. B Neuropsychiatr. Genet. | pmid:17230501 |
Wasserman SI | The mast cell and theophylline in asthma. | 1985 | Am. J. Med. | pmid:3002176 |
Fitscha P et al. | Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. | 1985 | Am. J. Hematol. | pmid:3885723 |
Sinzinger H et al. | Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. | 1991 | Am. J. Hematol. | pmid:1899965 |
Kawabe Y et al. | Genesis and recovery of ethanol-induced gastric lesions in rats: possible involvement of prostaglandin D2. | 1989 | Am. J. Gastroenterol. | pmid:2916522 |
Song HH et al. | Anti-inflammatory and anti-allergic effect of Agaricus blazei extract in bone marrow-derived mast cells. | 2012 | Am. J. Chin. Med. | pmid:22928836 |
Paolini JF et al. | Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. | 2008 | Am. J. Cardiol. | pmid:18308010 |
Okano M et al. | Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. | 2006 May-Jun | Am J Rhinol | pmid:16871941 |
Nishino S et al. | Salivary prostaglandin concentrations: possible state indicators for major depression. | 1989 | Am J Psychiatry | pmid:2627202 |
Naclerio RM | Additional properties of cetirizine, a new H1 antagonist. | 1991 May-Jun | Allergy Proc | pmid:1680095 |
Guyer BJ et al. | Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis. | 2006 May-Jun | Allergy Asthma Proc | pmid:16913263 |
Horak F et al. | Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. | 1998 | Allergy | pmid:9491231 |
Howarth PH | Mediators of nasal blockage in allergic rhinitis. | 1997 | Allergy | pmid:9353555 |
Abdelaziz MM et al. | The potential of active metabolites of antihistamines in the management of allergic disease. | 2000 | Allergy | pmid:10843422 |
Ito W et al. | Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. | 2007 | Allergy | pmid:17362253 |
Holgate ST et al. | The contribution of mast cell mediators to acute allergic reactions in human skin and airways. | 1988 | Allergy | pmid:2451448 |
Wang XS et al. | PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease. | 2007 | Allergy | pmid:17508965 |
Church MM et al. | The mediator and cellular basis of the allergic response. | 1988 | Allergy | pmid:2462372 |
Okayama Y et al. | In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. | 1994 | Allergy | pmid:7518654 |
Gulliksson M et al. | Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. | 2006 | Allergy | pmid:17073880 |
Takafuji S et al. | Release of granule proteins from human eosinophils stimulated with mast-cell mediators. | 1998 | Allergy | pmid:9821474 |
Pérez-Novo CA et al. | CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. | 2010 | Allergy | pmid:19839971 |
Ono E et al. | Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite. | 2008 | Allergy | pmid:18315738 |
Campbell AM et al. | Modulation of eicosanoid and histamine release from human dispersed lung cells by terfenadine. | 1993 | Allergy | pmid:7681268 |
Kanai K et al. | Effect of prostaglandin D2 on VEGF release by nasal polyp fibroblasts. | 2016 | Allergol Int | pmid:27091669 |
Akabane H et al. | Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells. | 2006 | Allergol Int | pmid:17130681 |
Ishimura M et al. | Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. | 2006 | Allergol Int | pmid:17130683 |
Oguma T et al. | Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. | 2008 | Allergol Int | pmid:18946232 |
Yoshimura T et al. | Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. | 2008 | Allergol Int | pmid:18797183 |
Higashi N et al. | Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. | 2012 | Allergol Int | pmid:22627848 |
Demoly P et al. | [Nose and sinus: anatomo-pathologic relations]. | 1998 | Allerg Immunol (Paris) | pmid:9631692 |
Kojima K et al. | Effect of PPARgamma ligands on the viability of gastric epithelial cells. | 2002 | Aliment. Pharmacol. Ther. | pmid:11966526 |
Anton RF and Randall CL | Central nervous system prostaglandins and ethanol. | 1987 | Alcohol. Clin. Exp. Res. | pmid:3105343 |
Amano N et al. | The effect of pentobarbital and ether anesthesia on rat brain PGD2 content. | 1989 | Agressologie | pmid:2610292 |
Matzkin ME et al. | Alterations in oxidative, inflammatory and apoptotic events in short-lived and long-lived mice testes. | 2016 | Aging (Albany NY) | pmid:26805572 |
MacIntyre DE et al. | Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators. | 1986 | Agents Actions Suppl. | pmid:3028106 |
Baumgarten CR et al. | Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammation. | 1992 | Agents Actions Suppl. | pmid:1462881 |
Kuiper J et al. | The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver. | 1989 | Agents Actions | pmid:2653002 |
Church MK et al. | Mast cells, neuropeptides and inflammation. | 1989 | Agents Actions | pmid:2473641 |
Ennis M et al. | Prostaglandin and histamine release from stimulated rat peritoneal mast cells. | 1984 | Agents Actions | pmid:6203356 |